Cytoreduction of Residual Tumor Burden Is Decisive for Prolonged Survival in Patients with Recurrent Brain Metastases—Retrospective Analysis of 219 Patients

SIMPLE SUMMARY: Appropriate therapies for brain metastases are still lacking and need further research, especially in terms of recurrent brain metastases. This is why we decided to highlight the importance of complete cytoreduction by addressing the impact of postoperative tumor burden as displayed...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jonas, Kaiser, Yannik, Wiestler, Benedikt, Bernhardt, Denise, Combs, Stephanie E., Delbridge, Claire, Meyer, Bernhard, Gempt, Jens, Aftahy, Amir Kaywan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605169/
https://www.ncbi.nlm.nih.gov/pubmed/37894435
http://dx.doi.org/10.3390/cancers15205067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605169/
https://www.ncbi.nlm.nih.gov/pubmed/37894435
http://dx.doi.org/10.3390/cancers15205067

Ejemplares similares